Anduril will not reach a $70 billion valuation by July 31, leaving the company below the surge target despite its recent funding. Anduril only reached a $61 billion mark in its May 2026 Series H led by Thrive Capital and Andreessen Horowitz, and the firm has raised over $12 billion since Palmer Luc…